Rare Case of Olmesartan Induced Enteropathy.

Olmesartan (brand name Benicar) is an antihypertensive drug clinicians commonly use to treat high blood pressure. Olmesartan induced enteropathy (OSE) is a rare entity that authors first identified in 2012. The etiological basis of OSE remains unclear, although authors have suggested that this condition could be due to alternations in cell mediated immune responses induced by the drug.

Trends in case fatality rate in pulmonary embolism according to stability and treatment.

Purpose: To determine categories of patients with pulmonary embolism in whom therapy has been reducing or failing to reduce case fatality rate.

Methods: Patients with acute pulmonary embolism were assessed from the Nationwide Inpatient Sample, 1999-2008. Trends of case fatality rates were assessed according to whether patients were stable or unstable and according to treatment within these groups.